{"SPADE_UN_30091": {"Sequence Information": {"Peptide Name": "", "Sequence": "GXK", "Sequence Length": 3, "Biological Activity": ["Anti-Gram+", "Anti-Gram-"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections.", "Pubmed ID": "25556094", "Reference": "Bioorg Med Chem Lett. 2015;25:542-546", "Author": "Kukowska M, Kukowska-Kaszuba M, Dzierzbicka K", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25556094"}], "SPADE ID": "SPADE_UN_30091", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00009", "Similarity": 1.0, "Sequence": "SGIPCTIGAAVAASIAVCPTTKCSKRCGKRKK"}, {"SPADE_ID": "SPADE_N_00025", "Similarity": 1.0, "Sequence": "GKNGVFKTISHECHLNTWAFLATCCS"}, {"SPADE_ID": "SPADE_N_00027", "Similarity": 1.0, "Sequence": "ASIVKTTIKASKKLCRGFTLTCGCHFTGKK"}], "Hemolytic Activity": "", "Target Organism": "Staphylococcus aureus ATCC 25923(MIC50=31.3µg/ml),Staphylococcus aureus ATCC 25923(MIC90=62.5µg/ml),Staphylococcus aureus ATCC 25923(MBC50=93.7µg/ml),Staphylococcus aureus ATCC 25923(MBC90=125.0µg/ml),Staphylococcus aureus ATCC 6538(MIC50=31.3µg/ml),Staphylococcus aureus ATCC 6538(MIC90=31.3µg/ml),Staphylococcus aureus ATCC 6538(MBC50=93.7µg/ml),Staphylococcus aureus ATCC 6538(MBC90=125.0µg/ml),Escherichia coli DSM 11250(MIC50=31.3µg/ml),Escherichia coli DSM 11250(MIC90=62.5µg/ml),Escherichia coli ATCC 8739(MIC50=62.5µg/ml),Escherichia coli ATCC 8739(MIC90=125.0µg/ml),Pseudomonas aeruginosa ATCC 9027(MIC50=375.0µg/ml),Pseudomonas aeruginosa ATCC 9027(MIC90=500.0µg/ml),Pseudomonas aeruginosa ATCC 9027(MBC50=1500.0µg/ml),Pseudomonas aeruginosa ATCC 9027(MBC90=2000.0µg/ml)"}}}